Clinical presentation pattern is more closely associated with treatment outcome than histologic subtypes in Castleman’s disease
Yujeong Hong(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Namkug Kim(Ulsan College), Sibaev Im, Yu Jeong Bang, Tae Yong Kim(Ulsan College), S. Park, Y. H. Park, D. W. Kim, S.-S. Yoon, Dae Seog Heo(Seoul National University)
Cited by 0
Related Papers
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2011|320
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
|Oncotarget|2017|87
A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platform
|Journal of Materials Chemistry|2012|67
Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib
|Cancer Research and Treatment|2018|66